OMKARCHEM.NS
Omkar Speciality Chemicals Limited [OMKARCHEM.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OMKARCHEM.NS Stock Summary
Top 10 Correlated ETFs
OMKARCHEM.NS
Top 10 Correlated Stocks
OMKARCHEM.NS
In the News
OMKARCHEM.NS Financial details
Company Rating
Buy
Market Cap
173.88M
Income
-164.94M
Revenue
193.58M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
59
Optionable
No
Shortable
Yes
Earnings
19 Dec 2023
P/E
-1.36
Forward P/E
-
PEG
0.01
P/S
0.75
P/B
-0.1
P/C
-
P/FCF
19.26
Quick Ratio
0.05
Current Ratio
0.15
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-8
EPS next Y
-
EPS next Q
-
EPS this Y
-725.51%
EPS next Y
-
EPS next 5Y
-639.71%
EPS last 5Y
-34.42%
Revenue last 5Y
-34.57%
Revenue Q/Q
-25.96%
EPS Q/Q
-29.21%
-
-
-
-
SMA20
12.5%
SMA50
12.5%
SMA100
-18.18%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
8%
ROC
-
Gross Margin
27%
Oper. Margin
-
Profit Margin
-55%
Payout
-
Shs Outstand
20.58M
Shs Float
12.33M
-
-
-
-
Target Price
-
52W Range
6.8-18.25
52W High
-53.61%
52W Low
+39.17%
RSI
44
Rel Volume
0.51
Avg Volume
22.19K
Volume
11.24K
Perf Week
-8.24%
Perf Month
-1.18%
Perf Quarter
8.44%
Perf Half Y
5.03%
-
-
-
-
Beta
-0.065
-
-
Volatility
0.14%, 0.49%
Prev Close
-1.18%
Price
8.35
Change
1.83%
OMKARCHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 93.1 | 20.73 | 27.64 | 21.96 | 11.18 | |
| Net income per share | -50.52 | -8.2 | -7.11 | 0.98 | -6.13 | |
| Operating cash flow per share | 12.61 | 0.67 | 1.95 | -7.99 | 0.43 | |
| Free cash flow per share | -13.85 | 0.56 | 1.94 | -8 | 0.43 | |
| Cash per share | 5.51 | 0.21 | 0.34 | 0.43 | 5.03 | |
| Book value per share | -60.79 | -71.96 | -78.96 | -77.06 | -83.18 | |
| Tangible book value per share | -60.86 | -72.02 | -79 | -77.06 | -83.18 | |
| Share holders equity per share | -60.79 | -71.96 | -78.96 | -77.06 | -83.18 | |
| Interest debt per share | 124.78 | 118.59 | 115.77 | 113.69 | 112.62 | |
| Market cap | 706.85M | 341.59M | 50.42M | 239.37M | 607.64M | |
| Enterprise value | 3.02B | 2.64B | 2.38B | 2.52B | 2.86B | |
| P/E ratio | -0.68 | -2.02 | -0.34 | 11.89 | -4.82 | |
| Price to sales ratio | 0.37 | 0.8 | 0.09 | 0.53 | 2.64 | |
| POCF ratio | 2.72 | 24.78 | 1.26 | -1.46 | 68.11 | |
| PFCF ratio | -2.48 | 29.82 | 1.27 | -1.46 | 68.11 | |
| P/B Ratio | -0.57 | -0.23 | -0.03 | -0.15 | -0.36 | |
| PTB ratio | -0.57 | -0.23 | -0.03 | -0.15 | -0.36 | |
| EV to sales | 1.58 | 6.18 | 4.19 | 5.58 | 12.45 | |
| Enterprise value over EBITDA | -7.04 | 430.34 | 2.17K | 30.85 | -60.28 | |
| EV to operating cash flow | 11.64 | 191.24 | 59.27 | -15.35 | 320.65 | |
| EV to free cash flow | -10.6 | 230.1 | 59.75 | -15.33 | 320.65 | |
| Earnings yield | -1.47 | -0.49 | -2.9 | 0.08 | -0.21 | |
| Free cash flow yield | -0.4 | 0.03 | 0.79 | -0.69 | 0.01 | |
| Debt to equity | -1.86 | -1.55 | -1.44 | -1.44 | -1.32 | |
| Debt to assets | 1.71 | 2.14 | 2.4 | 2.64 | 3.12 | |
| Net debt to EBITDA | -5.39 | 374.57 | 2.12K | 27.91 | -47.47 | |
| Current ratio | 0.19 | 0.12 | 0.16 | 0.26 | 0.15 | |
| Interest coverage | -2.14 | 0 | 0 | 0 | 0 | |
| Income quality | -0.21 | -0.12 | -0.36 | -5.21 | -0.07 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.06 | 0.04 | 0.03 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -2.1 | -0.17 | -0.01 | 0 | 0 | |
| Capex to revenue | -0.28 | -0.01 | 0 | 0 | 0 | |
| Capex to depreciation | -6.67 | -0.03 | 0 | -0.01 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 262.87 | 115.23 | 112.4 | 41.22 | 107.11 | |
| ROIC | -0.39 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | -0.76 | -0.16 | -0.15 | 0.02 | -0.17 | |
| Graham Net | -120.38 | -123.14 | -115.51 | -101.98 | -112.05 | |
| Working capital | -1.49B | -1.59B | -1.55B | -1.31B | -2.07B | |
| Tangible asset value | -1.25B | -1.48B | -1.63B | -1.58B | -1.71B | |
| Net current asset value | -2.26B | -2.34B | -2.3B | -1.98B | -2.08B | |
| Invested capital | -1.86 | -1.55 | -1.44 | -1.44 | -1.32 | |
| Average receivables | 772.96M | 0 | 129.79M | 353.96M | 234.48M | |
| Average payables | 539.89M | 191.84M | 190.68M | 141.12M | 100.49M | |
| Average inventory | 387.25M | 36.12M | 33.65M | 25.77M | 15.68M | |
| Days sales outstanding | 0 | 0 | 166.57 | 362.65 | 32.74 | |
| Days payables outstanding | 30.01 | 212.46 | 131.53 | 112.49 | 215.38 | |
| Days of inventory on hand | 7.13 | 30.55 | 28.04 | 14.5 | 39.69 | |
| Receivables turnover | 0 | 0 | 2.19 | 1.01 | 11.15 | |
| Payables turnover | 12.16 | 1.72 | 2.77 | 3.24 | 1.69 | |
| Inventory turnover | 51.21 | 11.95 | 13.02 | 25.17 | 9.2 | |
| ROE | 0.83 | 0.11 | 0.09 | -0.01 | 0.07 | |
| Capex per share | -26.46 | -0.11 | -0.02 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q1
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.58 | 2.06 | 3.07 | 2.44 | 1.82 | |
| Net income per share | -1.11 | -1.73 | -0.89 | -3.15 | -2.23 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 5.02 | 0 | 5.01 | 0 | |
| Book value per share | 0 | -79.79 | 0 | -82.78 | 0 | |
| Tangible book value per share | 0 | -79.79 | 0 | -82.78 | 0 | |
| Share holders equity per share | 0 | -79.79 | 0 | -82.78 | 0 | |
| Interest debt per share | 0.7 | 106.62 | 0.76 | 109.9 | 0.82 | |
| Market cap | 186.23M | 344.41M | 651.92M | 610.59M | 446.56M | |
| Enterprise value | 186.23M | 2.52B | 651.92M | 2.86B | 446.56M | |
| P/E ratio | -2.04 | -2.42 | -8.86 | -2.35 | -2.43 | |
| Price to sales ratio | 2.53 | 8.14 | 10.28 | 12.1 | 11.95 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | -0.21 | 0 | -0.36 | 0 | |
| PTB ratio | 0 | -0.21 | 0 | -0.36 | 0 | |
| EV to sales | 2.53 | 59.56 | 10.28 | 56.74 | 11.95 | |
| Enterprise value over EBITDA | -49.2 | -157.14 | 479.7 | -98.76 | -54.08 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | -0.12 | -0.1 | -0.03 | -0.11 | -0.1 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | -1.33 | 0 | -1.32 | 0 | |
| Debt to assets | 0 | 2.85 | 0 | 3.12 | 0 | |
| Net debt to EBITDA | 0 | -135.67 | 0 | -77.7 | 0 | |
| Current ratio | 0 | 0.16 | 0 | 0.15 | 0 | |
| Interest coverage | -0.6 | -1.88 | -0.17 | -2.12 | -0.72 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 55.73 | 0 | 76.58 | 0 | |
| ROIC | 0 | -0.06 | 0 | -0.08 | 0 | |
| Return on tangible assets | 0 | -0.05 | 0 | -0.09 | 0 | |
| Graham Net | 0 | -109.94 | 0 | -111.51 | 0 | |
| Working capital | 2.63K | -2.02B | 3.19K | -2.07B | 3.33K | |
| Tangible asset value | 0 | -1.64B | 0 | -1.71B | 0 | |
| Net current asset value | 2.63K | -2.03B | 3.19K | -2.08B | 3.33K | |
| Invested capital | 0 | -1.33 | 0 | -1.32 | 0 | |
| Average receivables | 224.17M | 19.2M | 19.2M | 10.31M | 10.31M | |
| Average payables | 51.22M | 70.63M | 70.63M | 49.27M | 49.27M | |
| Average inventory | 6.6M | 11.39M | 11.39M | 9.08M | 9.08M | |
| Days sales outstanding | 0 | 81.67 | 0 | 36.76 | 0 | |
| Days payables outstanding | 0 | 369.27 | 0 | 216.04 | 0 | |
| Days of inventory on hand | 0 | 59.56 | 0 | 39.81 | 0 | |
| Receivables turnover | 0 | 1.1 | 0 | 2.45 | 0 | |
| Payables turnover | 0 | 0.24 | 0 | 0.42 | 0 | |
| Inventory turnover | 0 | 1.51 | 0 | 2.26 | 0 | |
| ROE | 0 | 0.02 | 0 | 0.04 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
OMKARCHEM.NS Frequently Asked Questions
What is Omkar Speciality Chemicals Limited stock symbol ?
Omkar Speciality Chemicals Limited is a IN stock and trading under the symbol OMKARCHEM.NS
What is Omkar Speciality Chemicals Limited stock quote today ?
Omkar Speciality Chemicals Limited stock price is $8.35 today.
Is Omkar Speciality Chemicals Limited stock public?
Yes, Omkar Speciality Chemicals Limited is a publicly traded company.
Company Profile
- Volume Average 22.19K
- Market Capitalization 173.88M
- Employee 59
- CEO Mr. Pravin Shivdas Herlekar
- Headquarters Thane,IN
- IPO Date 2011-02-10
-
Website
https://www.omkarchemicals.com 
Omkar Speciality Chemicals Limited manufactures and sells specialty chemicals and intermediates for chemical and allied industries in India and internationally. It provides a range of organic, inorganic, and organo inorganic intermediates. The company offers selenium derivatives, iodine derivatives, resolving agents, and advance intermediates. Its products have applications in the pharmaceuticals, neutraceuticals, fragrances and flavours, foods, poultry and veterinary, glass and ceramics, and electro plating segments. Omkar Speciality Chemicals Limited also exports its products to Europe, Canada, Asia, South America, and Australia. The company was incorporated in 1983 and is based in Thane, India.
